 ChromaDex Corp NASDAQ: CDXC dropped over 20 during the premarket despite its announcement over plans to appeal a court ruling issued by the U.S. District Court for the District of Delaware in a patent infringement lawsuit against Elysium Health. Related: ChromaDex Shares Jump on Tru Niagens Launch In Walmart Stores. 